Tracked deals
10
10 tracked deals across 2019-2026.
Private Equity Firm
Healthcare
QHP Capital
Raleigh, North Carolina, United States
QHP Capital invests in life sciences and pharma services companies with proven products, services, and enabling technologies, partnering with founders and management teams to create long-term value. The firm is based in the Research Triangle Park area of North Carolina and is the management company for NovaQuest Private Equity.
- Focus Areas
- Life sciences, Pharmaceutical services, Healthcare services
- Website
- www.qhpcapital.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
8 buyout · 1 addon · 1 growth capital
QHP Capital Acquisition Volume by Year
Last 6 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
- Buyer
- Lexitas Pharma Services, QHP Capital
- Target
- Erie Retina Research, CASExERIE, LLC, Element Erie: Imaging & Reading Center PLLC
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Buyout
Lexitas Pharma Services (a QHP Capital portfolio company) acquired Erie Retina Research, along with CASExERIE and the assets of Element Erie: Imaging & Reading Center, to expand its retina-focused clinical research platform. Erie Retina Research will operate as a wholly owned subsidiary of Lexitas, CASExERIE will continue to operate within Erie Retina Research, and Element Erie’s imaging/reading capabilities will be integrated into Lexitas’ trial services.
-
September 30, 2024
- Buyer
- Spectra Medical Devices, LLC, QHP Capital
- Target
- XL Precision Technologies Ltd.
- Seller
- Rubicon Partners Industries
- Industry
- Medical Devices
- Location
- England, United Kingdom
- Type
- Addon
Spectra Medical Devices, a portfolio company of QHP Capital, has closed its acquisition of XL Precision Technologies Ltd., a Stockton‑on‑Tees based CDMO that manufactures precision micro-components, complex tubular components, and sub‑assemblies for the medical device industry. Rubicon Partners Industries, which acquired XL‑PT in 2008, was the seller; the deal expands Spectra's development and precision‑manufacturing capabilities to better serve medical device OEMs.
-
February 21, 2024
- Buyer
- QHP Capital
- Target
- Univo IRB (formerly Principal IRB)
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Buyout
QHP Capital has acquired Principal IRB and relaunched the business as Univo IRB, a next-generation institutional review board focused on agile IRB review services for clinical trials. The investment positions QHP to build and scale a tech-enabled life sciences services platform, leveraging Univo's accredited IRB team and industry-focused technologies to support sponsors, CROs, and device companies.
-
October 9, 2023
- Buyer
- QHP Capital
- Target
- Applied StemCell
- Industry
- Biotechnology
- Location
- California, United States
- Type
- Buyout
QHP Capital has acquired Applied StemCell, a Milpitas, California–based cell and gene therapy CRO/CDMO that provides iPSC and TARGATT gene‑editing platforms for biopharma and research clients. QHP said the acquisition will provide strategic capital and operating support to accelerate ASC's commercial expansion and scale its manufacturing and service capabilities for the cell and gene therapy market.
-
January 10, 2023
- Buyer
- QHP Capital, L.P., Stellus Capital Management, LLC
- Target
- COPILOT Provider Support Services, LLC
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Growth capital
QHP Capital, L.P. has made an investment in COPILOT Provider Support Services, a Maitland, Florida-based hub services platform that provides reimbursement and patient-access solutions to pharmaceutical companies and healthcare providers. Stellus Capital Management provided unitranche financing and an equity co-investment to support QHP's investment and the company's continued growth and capability expansion.
-
October 27, 2022
- Buyer
- QHP Capital, L.P.
- Target
- AutoCruitment, LLC
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Type
- Buyout
QHP Capital, the management company for NovaQuest Private Equity, has acquired AutoCruitment, a digital patient recruitment platform that helps pharma, biotech and CROs identify, screen and recruit patients for clinical trials. Monroe Capital provided a senior credit facility to support the acquisition, and QHP says the investment will support continued growth and capability expansion of AutoCruitment's digital patient recruitment offerings.
-
- Buyer
- QHP Capital, NovaQuest Private Equity
- Target
- Lexitas Pharma Services
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Buyout
QHP Capital, the management company for NovaQuest Private Equity, has acquired Lexitas Pharma Services, a Durham-based full-service ophthalmology contract research organization (CRO). The private equity investment is intended to support Lexitas’s continued growth and capability expansion in ophthalmic clinical trial services for biopharmaceutical and medical device clients.
-
February 23, 2021
- Buyer
- NovaQuest Private Equity
- Target
- Pro-ficiency
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Buyout
NovaQuest Private Equity has acquired a majority interest in Pro-ficiency, a Durham, North Carolina–based provider of simulation-based clinical trial training, compliance solutions, and analytics for sponsors and CROs. The growth equity investment will support Pro-ficiency's expansion of its platform, content, and team; deal terms were not disclosed.
-
January 19, 2021
- Buyer
- NovaQuest Private Equity
- Target
- CoreRx, Inc.
- Seller
- Affiliates of Signet Healthcare Partners
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Buyout
NovaQuest Private Equity acquired CoreRx, Inc., a Clearwater, Florida–based contract development and manufacturing organization (CDMO). Affiliates of Signet Healthcare Partners will retain a minority stake; Goldman Sachs Specialty Lending Group provided debt financing. NovaQuest said the investment will support continued growth and capability expansion of CoreRx's clinical and commercial CDMO services.
-
June 12, 2019
- Buyer
- CutisPharma, Inc., NovaQuest Private Equity (QHP Capital)
- Target
- Silvergate Pharmaceuticals, Inc.
- Industry
- Pharmaceuticals
- Location
- Colorado, United States
- Type
- Buyout
CutisPharma, majority-backed by NovaQuest Private Equity (now QHP Capital), has acquired Silvergate Pharmaceuticals and the combined company will be rebranded as Azurity Pharmaceuticals. The transaction consolidates complementary specialty pharmaceutical portfolios and capabilities—combining CutisPharma’s recently launched products with Silvergate’s SG-05 pipeline submission—and is supported by debt financing arranged by Goldman Sachs Specialty Lending Group.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
6 tracked deals by QHP Capital.
Pharmaceuticals Buyers & Acquisitions
2 tracked deals by QHP Capital.
Biotechnology Buyers & Acquisitions
1 tracked deal by QHP Capital.
Medical Devices Buyers & Acquisitions
1 tracked deal by QHP Capital.
Acquisitions in North Carolina
3 tracked deals by QHP Capital.
Acquisitions in Florida
2 tracked deals by QHP Capital.
Acquisitions in California
1 tracked deal by QHP Capital.
Acquisitions in Colorado
1 tracked deal by QHP Capital.
Selling a company? Get in front of buyers like QHP Capital
Turn tracked acquisition activity into an outreach-ready buyer list.